STUDY OF ASSESSING RISK OF DIABETES MELLITUS IN DEVELOPING OSTEOPOROSIS
Phase 1
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/06/019562
- Lead Sponsor
- ANUPA JOH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
GROUP A-PATIENTS WITH TYPE II DIABETES MELITUS
GROUP B-PATIENTS WITH OUT TYPE II DIABETES MELITUS
Exclusion Criteria
PATIENTS WITH CKD(GFR 60 ML/MIN)
MALABSORPTION SYNDROMES
CHRONIC PANCREATITIS
PARATHYROID GLAND DISORDERS
INFLAMMATORY DISEASES SUCH AS RHEUMATOID ARTHRITIS, SLE
ON TREATMENT WITH DIURETICS, ANTICONVULSANTS, THIAZOLIDINEDIONES, FIBRATES, IMMUNOSUPPRESSANTS, STEROIDS.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO ASSESS AND COMPARE THE BONE MINERAL DENSITY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS VS NON DIABETIC PATIENTSTimepoint: 12.1.2019 to 31.07.2019
- Secondary Outcome Measures
Name Time Method TO ASSESS AND COMPARE THE BONE MINERAL DENSITY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH MICROVASCULAR COMPLICATIONS VS DIABETIC PATIENTS WITHOUT MICROVASCULAR COMPLICATIONSTimepoint: 12.1.2019 to 31.07.2019